Trials / Completed
CompletedNCT01661309
Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians - Clinical Trial
To Critically Investigate and Evaluate Supplementary Vitamin B12 Effects on Elevated Homocysteine Levels of Vegetarians, Who May Have a Resultant Susceptibility to Hyperhomocysteinemia Related Diseases.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of West London · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Vegetarians are known to be deficient in vitamin B12, due to a lack or absence of dietary animal produce, which can elevate homocysteine. There is strong evidence indicating that elevated plasma total homocysteine (tHcy) is a contributor to chronic conditions, such as primary cardiovascular disease (CVD). The study hypothesis is: There will be a significant decrease in plasma tHcy of vegetarians following the intervention by supplementary vitamin B12 (of the methylcobalamin type) and this will lead to a reduction of the risk of CVD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Inactive lozenge | Manufactured to mimic 1mg methylcobalamin lozenge |
| DIETARY_SUPPLEMENT | Methylcobalamin | Aimed at reducing plasma tHcy. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-08-09
- Last updated
- 2014-05-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01661309. Inclusion in this directory is not an endorsement.